Europe raises 7.4B euros for coronavirus response

By The Science Advisory Board staff writers

May 5, 2020 -- On May 4, a group of nations and the European Commission raised 7.4 billion euros ($8 billion U.S.) to help make up for funding shortfalls in combating the COVID-19 outbreak. The funding will be used for a variety of purposes, including the development of diagnostics and vaccines.

The fundraising event was held in response to a call for more money to respond to COVID-19 by the Global Preparedness Monitoring Board (GPMB), a body convened by the World Health Organization (WHO) and World Bank Group.

The initial 7.4 billion euros from donors around the world included 1.4 billion euros ($1.5 billion) by the European Commission. The event was co-convened by the European Union, Canada, France, Germany, Italy, Japan, Saudi Arabia, Norway, Spain, and the United Kingdom.

In support of the GPMB's call to action, the European Commission is developing coordinated responses to COVID-19. This includes launching the Access to COVID-19 Tools (ACT) Accelerator for the research, development, and equitable distribution of vaccines and other lifesaving therapeutics and diagnostic treatments.

The funds raised will be channeled through recognized global health organizations such as GAVI (formerly the Global Alliance for Vaccines and Immunization), the Coalition for Epidemic Preparedness Innovations (CEPI), and the Vaccines Alliance. The goal will be to develop and deploy as quickly as possible diagnostics, treatments, and vaccines, according to European Commission leaders.

Funding floodgates open for COVID-19 research
The impacts of the COVID-19 pandemic are being felt around the world. Researchers are working at a record-setting pace to understand the novel coronavirus...
WHO ups coronavirus mortality rate to 3.4%
The World Health Organization (WHO) has raised its estimate of the mortality rate of patients infected with the novel coronavirus to 3.4% globally, up...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter